middle.news
Artrya Advances US Expansion with $80M Raise and FDA Clearance Momentum
8:33am on Tuesday 1st of September, 2026 AEST
•
Healthcare
Read Story
Artrya Advances US Expansion with $80M Raise and FDA Clearance Momentum
8:33am on Tuesday 1st of September, 2026 AEST
Key Points
Three US health systems contracted for Salix® platform
FDA clearance obtained for Coronary Plaque module
$80 million capital raised to support US rollout
SAPPHIRE clinical study progressing across six major centres
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE